Marshall Wace North America’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $9.48M | Sell |
214,034
-77,955
| -27% | -$3.45M | 0.04% | 366 |
|
|
2021
Q2 | $16.6M | Sell |
291,989
-169,712
| -37% | -$9.64M | 0.07% | 287 |
|
|
2021
Q1 | $34.6M | Sell |
461,701
-259,407
| -36% | -$19.4M | 0.14% | 169 |
|
|
2020
Q4 | $62.4M | Buy |
721,108
+299,169
| +71% | +$25.9M | 0.28% | 90 |
|
|
2020
Q3 | $25.8M | Buy |
+421,939
| New | +$25.8M | 0.17% | 156 |
|
|
2020
Q2 | – | Sell |
-9,482
| Closed | -$272K | – | 1438 |
|
|
2020
Q1 | $272K | Buy |
+9,482
| New | +$272K | ﹤0.01% | 862 |
|
|
2019
Q4 | – | Sell |
-167,060
| Closed | -$23.4M | – | 1555 |
|
|
2019
Q3 | $23.4M | Buy |
167,060
+40,843
| +32% | +$5.73M | 0.13% | 158 |
|
|
2019
Q2 | $23.1M | Sell |
126,217
-414,191
| -77% | -$75.8M | 0.14% | 139 |
|
|
2019
Q1 | $86M | Buy |
540,408
+53,704
| +11% | +$8.54M | 0.61% | 44 |
|
|
2018
Q4 | $46.6M | Sell |
486,704
-2,444
| -0.5% | -$234K | 0.45% | 64 |
|
|
2018
Q3 | $69.1M | Sell |
489,148
-38,468
| -7% | -$5.43M | 0.47% | 57 |
|
|
2018
Q2 | $82.6M | Sell |
527,616
-104,484
| -17% | -$16.4M | 0.47% | 46 |
|
|
2018
Q1 | $102M | Sell |
632,100
-4,917
| -0.8% | -$792K | 0.51% | 40 |
|
|
2017
Q4 | $105M | Buy |
637,017
+580,056
| +1,018% | +$95.5M | 0.58% | 32 |
|
|
2017
Q3 | $3.53M | Sell |
56,961
-285,277
| -83% | -$17.7M | 0.02% | 645 |
|
|
2017
Q2 | $27.4M | Sell |
342,238
-157,667
| -32% | -$12.6M | 0.2% | 131 |
|
|
2017
Q1 | $35.5M | Buy |
+499,905
| New | +$35.5M | 0.28% | 102 |
|